Elastagen

Elastagen is a clinical-stage medical company with an advanced product pipeline based on human tropoelastin, a groundbreaking medical biomaterial. The company’s products can repair and enhance the skin by using elastin to maintain its elasticity and softness. Elastin is a crucial component of human tissue that requires the ability to stretch and recoil, such as in the skin, lungs, arteries, and elastic ligaments. Elastagen has developed a synthetic form of the elastin protein, which is identical to the naturally occurring protein in the human body. Elastagen’s platform technology has potential applications in many areas, including skin rejuvenation, scar remodeling, and tissue repair. The Elastagen technology was established after acquiring the intellectual property rights for elastin technology developed by Professor Weiss at the University of Sydney. Since then, the company has successfully attracted funding from several leading Australian and overseas life science venture capital groups. Elastagen's operations have expanded from its base in Australia to include production in Europe and clinical operations in the UK.